Substitution of fractionated for unfractionated heparin during high-risk percutaneous coronary intervention: has the problem been solved?
Eisenberg
Mark J
MJ
D015906:Angioplasty, Balloon, Coronary; D017024:Chemotherapy, Adjuvant; D017984:Enoxaparin / Q000009:adverse effects*; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000188:drug therapy / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D015912:Thrombolytic Therapy / Q000009:adverse effects*
D017984:Enoxaparin; D005343:Fibrinolytic Agents; D006493:Heparin